Projects per year
Fingerprint
Dive into the research topics where Steve Oghumu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
X chromosome inactivation in sex disparities to substance use disorder
Oghumu, S. (PI)
National Institute on Drug Abuse
08/15/21 → 05/31/25
Project: Research
-
Mechanisms of Oral Cancer Inhibition by Bioactive Phytochemicals in Black Raspberries
Oghumu, S. (PI)
09/1/17 → 08/31/18
Project: Research
-
Efficacy of anti-LAG3 and anti-PD-1 combination checkpoint inhibitor therapy against head and neck squamous cell carcinoma in a genetically engineered mouse model
Lamenza, F. F., Roth, P., Upadhaya, P., Shrestha, S., Jagadeesha, S., Kazmierowicz, N., Horn, N., Pracha, H., Dasari, S. & Oghumu, S., 2025, In: OncoImmunology. 14, 1, 2477872.Research output: Contribution to journal › Article › peer-review
Open Access -
Targeting macrophage migration inhibitory factor to inhibit T cell immunosuppression in the tumor microenvironment and improve cancer outcomes in head and neck squamous cell carcinoma
Pracha, S. H., Shrestha, S., Ryan, N., Upadhaya, P., Lamenza, F. F., Jagadeesha, S., Jordanides, P., Roth, P., Springer, A. & Oghumu, S., Jan 2025, In: Oral Oncology. 160, 107126.Research output: Contribution to journal › Article › peer-review
-
Berries vs. Disease: Revenge of the Phytochemicals
Lamenza, F. F., Upadhaya, P., Roth, P., Shrestha, S., Jagadeesha, S., Horn, N., Pracha, H. & Oghumu, S., Jan 2024, In: Pharmaceuticals. 17, 1, 84.Research output: Contribution to journal › Review article › peer-review
Open Access1 Scopus citations -
BRAF V600E gene mutation is present in primary intraosseous Rosai-Dorfman disease
Cevik, L., Satturwar, S., Jones, D., Mayerson, J., Oghumu, S. & Iwenofu, O. H., Dec 2024, In: Human Pathology. 154, 105702.Research output: Contribution to journal › Letter › peer-review
-
Host derived macrophage migration inhibitory factor expression attenuates anti-tumoral immune cell accumulation and promotes immunosuppression in the tumor microenvironment of head and neck squamous cell carcinoma
Ryan, N., Lamenza, F., Shrestha, S., Upadhaya, P., Springer, A., Jordanides, P., Pracha, H., Roth, P., Kumar, R., Wang, Y., Vilgelm, A. E., Satoskar, A. & Oghumu, S., Oct 2024, In: Biochimica et Biophysica Acta - Molecular Basis of Disease. 1870, 7, 167345.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations